Next Article in Journal
Genomic and Biological Profile of a Novel Bacteriophage, Vibrio phage Virtus, Which Improves Survival of Sparus aurata Larvae Challenged with Vibrio harveyi
Next Article in Special Issue
Monitoring and Surveillance of Small Ruminant Health in The Netherlands
Previous Article in Journal
Analytical Performances of the COVISTIXTM Antigen Rapid Test for SARS-CoV-2 Detection in an Unselected Population (All-Comers)
Previous Article in Special Issue
Comparative Whole Genome Analysis of an Anaplasma phagocytophilum Strain Isolated from Norwegian Sheep
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pathogens
Volume 11
Issue 6
10.3390/pathogens11060629
pathogens-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Prevalence of Histopathological Features of Pneumonia in Goats with Symptomatic Caprine Arthritis-Encephalitis

by
Agata Moroz
1,
Michał Czopowicz
1,*,
Małgorzata Sobczak-Filipiak
2,
Izabella Dolka
2,
Magdalena Rzewuska
3,
Magdalena Kizerwetter-Świda
3,
Dorota Chrobak-Chmiel
3,
Marcin Mickiewicz
1,
Lucjan Witkowski
1,
Olga Szaluś-Jordanow
4,
Tomasz Nalbert
1,
Adrian Valentin Potârniche
5,
Karolina Barszcz
6,
Iwona Markowska-Daniel
1,
Ryszard Puchała
7,
Emilia Bagnicka
8 and
Jarosław Kaba
1,*
1
Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences–SGGW, Nowoursynowska 159c, 02-776 Warsaw, Poland
2
Department of Pathology and Veterinary Diagnostics, Institute of Veterinary Medicine, Warsaw University of Life Sciences–SGGW, Nowoursynowska 159c, 02-776 Warsaw, Poland
3
Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences–SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland
4
Department of Small Animal Diseases with Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences–SGGW, Nowoursynowska 159c, 02-776 Warsaw, Poland
5
Department of Infectious Diseases, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, Mănăștur Str. 3-5, 400372 Cluj, Romania
6
Department of Morphological Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences–SGGW, Nowoursynowska 159c, 02-776 Warsaw, Poland
7
Applied Physiology Unit, Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland
8
Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postępu 36A, Jastrzębiec, 02-552 Magdalenka, Poland
*
Authors to whom correspondence should be addressed.
Pathogens 2022, 11(6), 629; https://doi.org/10.3390/pathogens11060629
Submission received: 1 April 2022 / Revised: 25 May 2022 / Accepted: 27 May 2022 / Published: 30 May 2022
(This article belongs to the Special Issue Emerging Infections in Small Ruminants)
Browse Figures
Versions Notes

Abstract

:
Chronic interstitial pneumonia (CIP) is a main pathology of sheep infected with small ruminant lentivirus (SRLV). Caprine arthritis-encephalitis (CAE) is caused by the same pathogen; however, the presence of CIP has been only occasionally reported in SRLV-infected goats. We carried out a cross-sectional study to determine the prevalence of histopathological lesions indicative of CIP in goats with symptomatic CAE, and to investigate whether CIP was associated with a higher prevalence of other types of pneumonia (purulent bronchopneumonia, fibrinous pleuropneumonia) or bacterial infections. Lung specimens and bronchial swabs were collected for histopathological and bacteriological examination, respectively, from 116 goats from a CAE-affected herd. All goats were euthanized due to severe clinical signs of CAE. The goats were seropositive for SRLV infection in two different ELISAs and the presence of SRLV antigen in the lung tissue was confirmed by immunohistochemistry. Histopathologically, pneumonia of any type was confirmed in 82 goats (70.7%) and CIP was present in 67 goats (57.8%). In most goats, the severity of the histopathological features of pneumonia was mild. Bacteria were detected in bronchial swabs from 73 goats (62.9%). CIP proved to be significantly positively linked to the occurrence of purulent bronchopneumonia (p < 0.001), fibrinous pleuropneumonia (p = 0.001), and of the infection of lungs with bacteria capable of causing pneumonia (p = 0.050). The causal character of these associations should be considered and warrants further investigation.

1. Introduction

Caprine arthritis-encephalitis (CAE) is a goat disease caused by a small ruminant lentivirus (SRLV). Its counterpart in sheep is maedi-visna disease. SRLV is a heterogenous viral species comprising at least four genotypes and many genetic subtypes with genotype A (traditionally referred to as maedi-visna virus (MVV)-like) and B (CAEV-like) distributed worldwide [1]. Even though it has so far been well-evidenced that SRLV easily crosses the interspecies barrier between sheep and goats [2,3,4,5,6,7] and both diseases demonstrate a similar chronic progressive course with a long incubation period, the two small ruminant species tend to show distinct clinical signs [8]. A progressive arthritis in goats and a progressive interstitial pneumonia in sheep are the main clinical manifestations of SRLV infection, usually accompanied by emaciation and sometimes by indurative mastitis [9].
Maedi-visna disease is widespread in many European countries, with Greek and Spanish sheep populations being the most extensively affected [10]. In Poland, the flock-level seroprevalence ranges from <1% to 50% with the average individual-level seroprevalence of 15% [10,11]. Despite the fact that for at least two decades genotype A (MVV-like) has been detected in goat populations in many countries [12] including Poland [13,14,15], the knowledge of the occurrence of pulmonary lesions in the course of CAE is very limited. In fact, only some early studies have indicated and described maedi-visna-like pulmonary lesions in SRLV-infected goats [16,17,18,19]. Thenceforth, SRLV infection has only been mentioned as a potential but infrequent cause of interstitial pneumonia in goats [8]. On the other hand, interstitial pneumonia has also been observed in goats infected with genotype B [20], which is traditionally regarded as a caprine SRLV genotype and has also been shown to occur throughout Poland [13,14,15].
In Poland, CAE is a widespread disease, with herd-level seroprevalence exceeding 70% [21], and goats with clinical signs of arthritis and emaciation are present in most infected herds [22]. Despite this fact, farmers decide not to introduce test-and-cull control programs mainly due to financial constraints. Some herds practice early weaning of kids from infected does, usually with only moderate successes [23]. Most farmers restrict themselves to culling goats showing clinical signs of CAE. One cross-sectional questionnaire study carried out in Polish goat herds indicated a significant relationship between the occurrence of SRLV infection and respiratory signs at a herd-level, although the link with arthritis and emaciation was much stronger [24]. For a few years, we cooperated with a large goat farm extensively affected by CAE, caused by SRLV genotype A, and we assisted in the elimination of a number of severely arthritic and emaciated goats. Therefore, we decided to use these goats to determine the prevalence of interstitial pneumonia in goats with symptomatic CAE and to investigate if interstitial pneumonia was associated with a higher prevalence of other types of pneumonia and bacterial infections of the lungs.

2. Results

2.1. Serological Status

Of 122 euthanized, goats 116 goats were seropositive for SRLV in two different ELISAs (ELISA based on the whole virus antigen (wELISA) and ELISA based on recombinant transmembrane (TM) and capsid (CA) antigens (TM/CA-ELISA)) and were hence enrolled in the further analyses. Their age ranged from 1 to 14 years with a median (IQR) of 6 (4 to 8) years. Given a high diagnostic specificity of both wELISA and TM/CA-ELISA and a very high true prevalence of SRLV infection in the herd from which the goats came, the diagnosis based on a double positive result was very likely to be true (positive predictive value of >99.9%). All 116 goats tested seropositive for PIV-3 infection and 70/116 goats for caseous lymphadenitis (CLA), which yielded a seroprevalence of 100% (CI 95%: 96.8–100%) and 60.3% (CI 95%: 51.2–68.8%), respectively.

2.2. Gross and Histopathological Lesions

None of goats showed any gross pulmonary lesions indicative of SRLV-associated pneumonia. Microscopic examination of the lung specimens revealed that pneumonia of any type was observed in 82/116 goats (70.7%; CI 95%: 61.8–78.2%). CIP was present in 67/116 goats (57.8%; CI 95%: 48.7–66.4%), PBP in 48/116 goats (41.4%; CI 95%: 32.8–50.5%), and FPP in 38/116 goats (32.8%; CI 95%: 24.9–41.7%). Pneumonia features were classified as mild in most goats, moderate only in a few goats, and severe in none (Figure 1).
A single pattern was observed in 32 goats (27.6% of all goats, and 39% of 82 goats with pneumonia confirmed histopathologically), of which most (n = 19, 59%) had CIP. A mixed pattern was observed in 50 goats, and only in 2 of them was CIP not involved (Figure 2).
The most commonly observed histopathological lesions were inflammatory infiltrates: interstitial (Figure 3A,B) in CIP and peribronchial and perivascular in PBP (Figure 4A). In CIP, they were followed by lymphatic nodules formation (Figure 3B) and interstitial connective tissue hyperplasia (Figure 3D), which were observed in more than half of the goats with this type of pneumonia, whereas smooth muscle hyperplasia (Figure 3C), interstitial septum thickening, and pneumocyte hyperplasia were much less common (Figure 3B). In PBP, other lesions such as focal emphysema and necrosis (Figure 4B,C) occurred in less than one-fifth of the goats. In FPP, subpleural connective tissue hyperplasia (Figure 5A) was observed most often and fibrin accumulation (Figure 5B,C) was present in less than one-fourth of the goats with this type of pneumonia (Table 1).
IHC was positive in 28/30 examined goats (93.3%). In 23/28 IHC-positive goats (82.1%), IHC staining was found both in bronchial epithelial cells and in macrophages located in the peribronchial interstitial tissue and in interalveolar septa (Figure 6B,D). In 3/28 goats (10.7%), IHC staining was present only in bronchial epithelial cells (Figure 6A), and, in 2/28 goats (7.2%), only in macrophages (Figure 6C). No specific labelling was observed in the SRLV-negative control (Figure 6E,F). The 2 goats that tested negative in IHC staining did not show histopathological lesions indicative of any type of pneumonia.

2.3. Bacterial Infections

Bacteria were detected in bronchial swabs from 73/116 goats (62.9%; CI 95%: 53.9–71.2%): a single bacterial species was isolated from 57/73 goats (78.1%) and two isolates from 16/73 goats (21.9%). Potential etiological agents of bacterial pneumonia were isolated from 40/116 goats (34.5%; CI 95%: 26.5–43.5%). Accidental/commensal microorganisms were detected in 33 goats. The most prevalent bacteria were Enterobacterales (mostly Escherichia coli), Trueperella pyogenes, Pasteurellaceae (Mannheimia hemolytica and Pasteurella multocida, virtually equally often), and staphylococci (mostly Staphylococcus aureus) (Table 2). Corynebacterium pseudotuberculosis was isolated from 6 goats and all of them were seropositive for CLA.

2.4. Relationship between Chronic Interstitial Pneumonia and other Respiratory System-Associated Conditions

CIP proved to be significantly positively linked to the occurrence of PBP (p < 0.001) and FPP (p = 0.001), which were 3–4-fold more likely in goats with than without CIP. CIP also appeared to be a potential risk factor for the infection of lungs with bacteria capable of causing pneumonia. On the other hand, it was not significantly related to CLA (neither seropositive status nor the presence of the etiological agent), the presence of accidental/commensal microorganisms in the lungs, or the concentration of antibodies against PIV-3 (Table 3).

3. Discussion

Our study shows that histopathological features of CIP were present in roughly 50% to 60% of the goats with symptomatic CAE caused by SRLV genotype A. Although they were mild in most of these goats, they appeared to be significantly linked to the occurrence of other types of pneumonia as well as bacterial infections of the lungs.
Lower respiratory tract and lung pathologies are a common health problem in goats [8]; however, their prevalence is vastly linked to the environmental factors and management system and varies considerably among geographical regions [25]. Few disease surveys have been published on the prevalence of pneumonia in goats, and they come from outside Europe. A large-scale survey on the prevalence of pneumonia in 374 slaughtered goats in Ethiopia revealed histopathological features of pneumonia in roughly 17% of them, and 30% of these animals had lesions indicating interstitial pneumonia [26]. On the other hand, the prevalence of lung lesions on gross examination in over 1.5 thousand slaughtered goats was less than 3% [27]. In light of these results, roughly 60% of goats with microscopic lesions indicative of CIP, 40% with PBP, and 30% with FPP appears to be a high proportion. Obviously, the goats enrolled in our study cannot be considered representative for the Polish goat population as they were severely affected by CAE. On the other hand, in Polish goats, respiratory signs have been observed in over 80% of goat herds and this percentage increased during the first decade of the 21st century along with an increasing tendency to keep goats in barns without grazing [28]. This may indicate that respiratory tract pathologies are generally widespread in Polish goat population.
CIP is the leading pathology in the course of maedi-visna disease [29] and its severity correlates with peripheral provirus levels [30]. Although progressive arthritis is the main clinical manifestation of CAE, several studies and case reports have shown that interstitial pneumonia also develops in SRLV-infected goats [16,17,18,19,20,31]. Nevertheless, its prevalence in SRLV-infected goats has never been investigated in any large-scale disease survey. The results of our cross-sectional study indicate that CIP develops in a relatively high proportion of arthritic goats. This high prevalence may even be underestimated because we examined histologically only specimens from the cranial lobe, whereas cranioventral or caudal lobes appear to most often contain SRLV-associated lesions [32]. In a large-scale abattoir survey from Ethiopia, roughly 50% of slaughtered sheep and 30% of slaughtered goats with pneumonia in gross examination had histopathological lesions indicative of interstitial pneumonia [26]. The status of goats with respect to SRLV was not evaluated in this study, and the epidemiological situation of the population of 51 million Ethiopian goats is unknown; however, maedi-visna is present and likely widespread in the population of 40 million Ethiopian sheep [33,34,35]. Although this implies that most of the interstitial lesions revealed in this study could have been linked with SRLV infection, it must be underscored that histopathology can provide only a preliminary estimation of SRLV-associated pulmonary pathologies and definitive diagnosis requires the use of pathogen-specific modalities. A recent study from Iran revealed that a small proportion of microscopic lesions suggestive of maedi-visna occurred in sheep truly infected with SRLV [36]. Similar interstitial lesions may be produced, e.g., by infections with Mycoplasma spp., which tend to elude routine bacteriological diagnostics [37,38,39,40]. Goats are considered more susceptible to mycoplasmal infections than sheep [41], and M. ovipneumoniae seems to be the most prevalent species in sheep and goats in Europe [42,43], with M. arginine [44] and M. capricolum [45] occasionally detected in pulmonary lesions. In our study, we did not perform any diagnostic tests for these pathogens. Therefore, the potential concomitant role of various Mycoplasma spp. needs to be taken into account as an alternative explanation of the observed interstitial lesions, especially given the fact that cranio-ventral lobes of the lungs are considered a typical location for mycoplasmal pneumonia [46]. The occurrence of Mycoplasma spp. infections in Polish small ruminant populations has never been investigated; however, serosurveys carried out in bovine population over 10 years ago revealed the presence of specific antibodies in roughly one-fourth of cows [47]. This seroprevalence did not, however, correspond to the apparent status of examined cows which were mostly clinically healthy. IHC confirmed the presence of SRLV p28 capsid antigen in macrophages and bronchial epithelial cells of a representative sample of goats examined in our study. This allows us to assume that interstitial lesions are likely a manifestation of CAE. A negative result and variable intensity of IHC staining may result from the limited expression of viral antigen within the lesion, assay validity [48], fixation technique, and genetic differences of SRLV isolates [49]. Nevertheless, whether the high prevalence of CIP in goats with symptomatic CAE can be attributed solely to SRLV infection or is, at least to some extent, associated with concurrent chronic infections with other pathogens, including Mycoplasma spp., needs to be clarified. It must also be stressed that environmental conditions in the herd from which the goats came were poor, including low-quality ventilation. Insufficient ventilation is known to play a principal role in the development of respiratory tract infections [8]. Therefore, the role of environmental infections should also be taken into account in the evaluation of exposure of the study population to respiratory pathogens and the development of pathological lesions in the lungs.
The interstitial lesions observed in our study were mostly mild, and thus unlikely to have a direct impact on the goats’ clinical condition. More important is the fact that we revealed a statistically significant positive association between CIP and the two other types of pneumonia—PBP and FPP, which are usually of bacterial etiology [8]. Furthermore, we observed a significantly higher prevalence of the infection with potential etiological agents of bacterial pneumonia in goats with CIP. These observations may imply that CIP creates favorable conditions for the concurrent development of other pulmonary pathologies and infections. This observation appears to correspond to the phenomena observed in the course of maedi-visna: the mortality rate is usually low in uncomplicated cases; however, maedi-visna disease places sheep at an increased risk of secondary pulmonary infections which directly contribute to their death [29,50,51]. Nevertheless, pathophysiological studies investigating the ability of CIP to facilitate the development of other pneumonias and the potential molecular mechanism of such a relationship are lacking. Although SRLV is closely related to immunodeficiency lentiviruses (human, feline, bovine), it has never been shown to have any immunosuppressive potential [52,53]. In fact, long-lasting infection overstimulates the immune system, leading to the development of local inflammatory processes and tissue destruction [54,55]. In the organs such as lungs or mammary gland which have direct contact with the external environment, this could create a favorable background for the multiplication of pathogens inhabiting the respiratory tract, teat skin, or canal. The potential existence of this relationship has recently been suggested in terms of the mammary gland of goats with asymptomatic SRLV infection [56]. Obviously, such conclusions need to be drawn very cautiously from cross-sectional studies. Their design, in which both the disease and factors potentially contributing to its occurrence are being detected in animals at the same moment, precludes identifying which of them has emerged first. The knowledge of a right time sequence between the two phenomena (i.e., that exposure to the supposed cause precedes the disease) is essential to consider the relationship between them as causal [57]. In our situation, we may only expect that the goats enrolled in the study had been infected with SRLV since the first months of their life because SRLV spreads efficiently via both lactogenic and horizontal routes [58,59] and the infection had been widespread in the herd long before the goats were born. Moreover, goats in this herd were kept in a relatively small building which ensures their close and intensive mutual contact. We do not know, however, whether it was CIP or any of the two other pneumonia types that developed first. Therefore, our causal inferences should be considered as preliminary results which warrant further confirmation in prospective longitudinal studies.

4. Materials and Methods

4.1. Goats and Serological Testing

The cross-sectional study was carried out in the years 2016–2018 on female dairy goats of the Polish White Improved and Polish Fawn Improved breeds. The goats came from a large herd (roughly 500 dairy goats) located in western Poland. The herd practiced machine milking twice a day and were used to sell milk to a large dairy. Goats in this herd were housed in a concrete, former piggery building, with a low ceiling and poor gravity ventilation. Goats were kept on straw bedding and were not grazed on the pasture. Main forages were hay, haylage, or corn silage, and main concentrates were wheat and oat.
CAE was first diagnosed in the herd serologically in 2002 in a male goat purchased from another herd. It spread gradually, and, at the beginning of the 2010s, the within-herd seroprevalence approached 100% and the symptomatic form of CAE became common. SRLV circulating in the herd belonged to genotype A and its nucleotide sequence was the closest to the subtype A2 or A3 with 91% identity according to the Basic Local Alignment Search Tool (BLAST) of the National Center for Biotechnology Information (NCBI) [60]. Since the emergence of the first clinical cases of CAE, no regular control program had been in practice in this herd except for regular culling of goats severely affected by clinical signs indicative of CAE. Goats selected by the farmer for culling due to severe arthritis or emaciation were transported to the Warsaw Institute of Veterinary Medicine and humanely euthanized with pentobarbital sodium at a dose of 100 mg/kg i.v. (Morbital, Biowet Puławy, Poland) preceded by a deep general anesthesia with intramuscular mixture of ketamine (Ketamina, Biowet Puławy, Puławy, Poland) at a dose of 5 mg/kg and xylazine (Xylapan, Vetoquinol Biowet Sp. z o.o., Gorzów Wielkopolski, Poland) at a dose of 1 mg/kg. During euthanasia, blood was collected from the jugular vein into 10 mL dry tubes and left at +4 °C overnight for clotting. Then, the blood samples were centrifuged and tested serologically for SRLV using two indirect ELISAs—ELISA based of the whole virus antigen (ID Screen MVV/CAEV Indirect; ID.vet, Grabels, France) and ELISA based on recombinant transmembrane (TM) and capsid (CA) antigens (IDEXX MVV/CAEV p28 Ab Screening, IDEXX Laboratories, Westbrook, ME, USA). According to the manufacturers’ manuals, the following cut-off values were applied in testing: a sample-to-positive control ratio (S/P%) > 50% and S/P% > 110%, respectively. At these cut-off values, the assays’ diagnostic sensitivities (Se) were 92% and 99%, respectively, whereas their diagnostic specificities (Sp) were 92% and 97%, respectively [61,62]. The goats were included in further analyses only if they tested positive in both ELISAs (serial testing) to maximize the probability that they were truly infected with SRLV. The serum samples from these goats were also tested serologically for the presence of antibodies against phospholipase D produced by C. pseudotuberculosis in the course of CLA using ELITEST CLA ELISA (Hyphen Biomed, Neuville-sur-Oise, France) and for PIV-3 infection using a quantitative ELISA (Goat PIV-IgG ELISA Kit, ABclonal Technology, Woburn, USA). Both tests were performed according to the manufacturers’ manuals. The PIV-3 ELISA measured the concentration of IgG class antibodies to PIV-3 (ng/mL) and the cut-off value to classify a goat as seropositive was set at >7.5 ng/mL based on a previous study [63]. Blood collection was approved by the 3rd Local Ethics Committee in Warsaw (approval No. 31/2013). According to Polish legal regulations (the Act on the Protection of Animals Used for Scientific or Educational Purposes of 15 January 2015), no ethics committee permission was necessary for post-mortem examination.

4.2. Gross Examination

The necropsies of 122 goats were performed within one hour of death. Lungs were examined visually and by palpation in search for gross features suggestive of SRLV-associated pneumonia such as failure to collapse, enlargement, presence of rib impressions on the costal surface of the lungs, diffuse firmness, as well as dryness of cross-sections, and the presence of 1–2 mm white-grey granular patches in the parenchyma [50,64]. From each goat, a fragment of lung tissue 3 cm × 3 cm × 2 cm was collected from the ventral part of the cranial right pulmonary lobe, the one considered as most often affected by pneumonia [8], and fixed in the 10% buffered formalin for histopathological examination. Additionally, a bronchial swab from the tertiary bronchi from the same region was collected for bacteriological examination.

4.3. Histopathological Examination

After formalin fixation of the lung samples, they were embedded in paraffin (Paraplast, WITKO Group, Łódź, Poland) and cut at 3.0 µm of thickness using a rotational microtome. Then, specimens were routinely processed and stained with hematoxylin and eosin (H-E; Varistain Gemini, Thermo Fisher Scientific, Waltham, MA, USA), using Masson’s method to demonstrate collagen fibers of the connective tissue and Weigert’s method to demonstrate the fibrin.
The following lesions observed in the histopathological examination were subjectively assessed by a board-certified veterinary pathologist in terms of their severity as mild (1 point), moderate (2 points), and severe (3 points), and assigned to three types of pneumonia:
  • Chronic interstitial pneumonia (CIP) composed of six lesions [29,50,64,65,66]: (1) lymphatic nodules hyperplasia (peribronchial and perivascular); (2) interstitial (i.e., peribronchiolar and perialveolar) inflammatory infiltrates composed of lymphocytes, plasma cells, and macrophages; (3) interstitial connective tissue hyperplasia; (4) interalveolar septum thickening; (5) smooth muscle hyperplasia in the walls of the bronchioles; and (6) pneumocyte hyperplasia.
  • Purulent bronchopneumonia (PBP) composed of six lesions: (1) peribronchial inflammatory infiltrates mostly composed of neutrophils and some lymphocytes and plasma cells; (2) perivascular inflammatory infiltrates mainly composed of neutrophils, some lymphocytes, and plasma cells; (3) exudate rich in the neutrophils in the lumen of alveoli; (4) focal emphysema; (5) focal atelectasis; and (6) focal necrosis of lung parenchyma.
  • Fibrinous pleuropneumonia (FPP) composed of three lesions: (1) interstitial accumulation of fibrin, (2) subpleural accumulation of fibrin, and (3) subpleural connective tissue hyperplasia.
Congestion and lung edema were not included in the classification as all goats were pharmacologically sedated and euthanized, which is likely to be associated with congestion of alveolar capillaries and alteration of vascular permeability in the lungs [67].
For each type of pneumonia, a numerical score was calculated as the sum of points divided by the number of lesions making up the entire type (i.e., the average number of points). The score took values from 0 to 3 and was interpreted as follows based on former classifications in sheep [30]: 0–0.4, no HP lesions; >0.4–1.4, mild; >1.4–2.4, moderate; and >2.4, severe.
Lung specimens from 30 randomly selected goats were further evaluated by an immunohistochemistry (IHC) assay to detect SRLV p28 capsid antigen [48]. After dewaxing in xylene and rehydration in alcohols, the slides were microwaved in 0.02 M citrate buffer, pH 6.0, at 600 Watt for 12 min and then treated with 3% hydrogen dioxide solution for 10 min. The sections were incubated with the 1:20-diluted anti-CAEV (primary) antibody (MAb CAEV-63, CAEV-Co IgG1, CAEP10A1, VMRD, Pullman, WA, USA) overnight at 4 °C in a humid chamber [31]. After washing in TRIS-buffered saline, the sections were incubated with the 1:150-diluted polyclonal goat anti-mouse immunoglobulins conjugated with horseradish peroxidase (secondary antibody) (Gt a Mo immunoglobulins/HRP, P044701-2, Dako, Agilent Tech, Santa Clara, CA, USA), and then visualized with 3,3′-diaminobenzidine (DAB) (Liquid DAB+, K346811-2, Dako, Agilent Tech., Santa Clara, CA, USA). The sections were counterstained with Mayer’s hematoxylin (Htx, Mayers, S330930-2, Dako, Agilent Tech., Santa Clara, CA, USA) and mounted using the DPX medium (Sigma-Aldrich Co., St. Louis, MO, USA). Each IHC stain was performed in parallel with known SRLV-negative caprine control lung tissue (two goats seronegative to SRLV, from a herd free from SRLV infection) and an isotype-control antibody as the negative control (Mo IgG1, Negative Control, X093101-2, Dako, Agilent Tech, Santa Clara, CA, USA).

4.4. Bacteriological Examination

Bronchial swabs were delivered to the microbiology laboratory within 2 h of collection and inoculated on two Columbia agar plates supplemented with 5% sheep blood and one MacConkey agar plate (Graso Biotech, Starogard Gdański, Poland). One Columbia agar and the MacConkey agar plate were incubated for 48 h at 37 °C in aerobic conditions. The other Columbia agar plate was cultured for 72 h at 37 °C in microaerophilic conditions. The obtained isolates were initially characterized based on their colony and cell morphology. The identification of isolates to the species level was performed using an adequate API system (bioMérieux, Craponne, France) according to the manufacturer’s instructions. The following bacterial species were considered as potential etiological agents of bacterial pneumonia [8,68,69]: M. hemolytica, P. multocida, T. pyogenes, S. aureus, α-hemolytic streptococci, and C. pseudotuberculosis as an etiological agent of CLA. Other bacteria were considered as accidental/commensal microorganisms.

4.5. Statistical Analysis

Categorical variables were expressed as counts and percentages of animals in a group, and the 95% confidence intervals (CI 95%) for proportions were calculated using the Wilson score method [70]. The relationships between factors were analyzed using a maximum likelihood G test and reported as a prevalence ratio (PR) with CI 95% [57]. Numerical variables were presented as the median, interquartile range (IQR), and range, and compared between groups using a Mann–Whitney U test. All tests were two-sided. The significance level (α) was set at 0.05. Statistical analysis was performed in TIBCO Statistica 13.3 (TIBCO Software Inc., Palo Alto, CA, USA).

5. Conclusions

Mild to moderate microscopic features of CIP are present in roughly 50% to 60% of goats with advanced arthritis and emaciation caused by CAE. Histopathological features of other types of pneumonia occur significantly more often in goats with CIP. The causal character of this association should be considered and verified in prospective longitudinal studies.

Author Contributions

Conceptualization, A.M., M.C., M.S.-F., E.B. and J.K.; methodology, A.M., M.C., M.S.-F., I.D., M.R., M.K.-Ś., D.C.-C., K.B. and J.K.; software, M.C.; validation, M.S.-F. and I.D.; formal analysis, A.M., M.C. and J.K.; investigation, A.M., M.M., L.W., O.S.-J., T.N., A.V.P., M.S.-F., I.D., M.R., M.K.-Ś., D.C.-C. and K.B.; resources, J.K.; data curation, A.M. and M.C.; writing—original draft preparation, A.M., M.C. and J.K.; writing—review and editing, M.S.-F., I.D., M.R., M.K.-Ś., I.M.-D., E.B. and R.P.; visualization, A.M. and M.C.; supervision, J.K.; project administration, M.C. and J.K.; funding acquisition, J.K. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the KNOW (Leading National Research Centre) Scientific Consortium “Healthy Animal—Safe Food”, decision of the Ministry of Science and Higher Education No. 05–1/KNOW2/2015, grant number UMO-KNOW/2016/SGGW/PRO1/01/3.

Institutional Review Board Statement

Blood collection was approved by the 3rd Local Ethics Committee in Warsaw (approval No. 31/2013). According to Polish legal regulations (the Act on the Protection of Animals Used for Scientific or Educational Purposes of 15 January 2015), no ethics committee permission was necessary for post-mortem examination.

Informed Consent Statement

Written informed consent has been obtained from the goat herd’s owner to publish this paper.

Data Availability Statement

Data are available upon request from the corresponding authors.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Ramírez, H.; Reina, R.; Amorena, B.; de Andrés, D.; Martínez, H.A. Small ruminant lentiviruses: Genetic variability, tropism and diagnosis. Viruses 2013, 5, 1175–1207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Banks, K.L.; Adams, D.S.; McGuire, T.C.; Carlson, J. Experimental infection of sheep by caprine arthritis-encephalitis virus and goats by progressive pneumonia virus. Am. J. Vet. Res. 1983, 44, 2307–2311. [Google Scholar] [PubMed]
  3. Pasick, J. Maedi-visna virus and caprine arthritis-encephalitis virus: Distinct species or quasispecies and its implications for laboratory diagnosis. Can. J. Vet. Res. 1998, 62, 241–244. [Google Scholar]
  4. Shah, C.; Boni, J.; Huder, J.B.; Vogt, H.R.; Muhlherr, J.; Zanoni, R.; Miserez, R.; Lutz, H.; Schupbach, J. Phylogenetic analysis and reclassification of caprine and ovine lentiviruses based on 104 new isolates: Evidence for regular sheep-to-goat transmission and worldwide propagation through livestock trade. Virology 2004, 319, 12–26. [Google Scholar] [CrossRef] [Green Version]
  5. Pisoni, G.; Quasso, A.; Moroni, P. Phylogenetic analysis of small-ruminant lentivirus subtype B1 in mixed flocks: Evidence for natural transmission from goats to sheep. Virology 2005, 339, 147–152. [Google Scholar] [CrossRef] [Green Version]
  6. Pisoni, G.; Bertoni, G.; Puricelli, M.; Maccalli, M.; Moroni, P. Demonstration of coinfection with and recombination by caprine arthritis-encephalitis virus and maedi-visna virus in naturally infected goats. J. Virol. 2007, 81, 4948–4955. [Google Scholar] [CrossRef] [Green Version]
  7. Leroux, C.; Cruz, J.C.; Mornex, J.F. SRLVs: A genetic continuum of lentiviral species in sheep and goats with cumulative evidence of cross species transmission. Curr. HIV Res. 2010, 8, 94–100. [Google Scholar]
  8. Smith, M.C.; Sherman, D.M. Goat Medicine, 2nd ed.; Wiley: Blackwell, NJ, USA, 2009; pp. 348–359. [Google Scholar]
  9. Preziuso, S.; Taccini, E.; Rossi, G.; Renzoni, G.; Braca, G. Experimental Maedi Visna Virus Infection in sheep: A morphological, immunohistochemical and PCR study after three years of infection. Eur. J. Histochem. 2003, 47, 373–378. [Google Scholar] [CrossRef] [Green Version]
  10. de Miguel, R.; Arrieta, M.; Rodríguez-Largo, A.; Echeverría, I.; Resendiz, R.; Pérez, E.; Ruiz, H.; Pérez, M.; de Andrés, D.; Reina, R.; et al. Worldwide Prevalence of Small Ruminant Lentiviruses in Sheep: A Systematic Review and Meta-Analysis. Animals 2021, 11, 784. [Google Scholar] [CrossRef]
  11. Junkuszew, A.; Dudko, P.; Bojar, W.; Olech, M.; Osiński, Z.; Gruszecki, T.M.; Kania, M.G.; Kuźmak, J.; Czerski, G. Risk factors associated with small ruminant lentivirus infection in eastern Poland sheep flocks. Prev. Vet. Med. 2016, 127, 44–49. [Google Scholar] [CrossRef]
  12. Minguijón, E.; Reina, R.; Pérez, M.; Polledo, L.; Villoria, M.; Ramírez, H.; Leginagoikoa, I.; Badiola, J.J.; García-Marín, J.F.; de Andrés, D.; et al. Small ruminant lentivirus infections and diseases. Vet. Microbiol. 2015, 181, 75–89. [Google Scholar] [CrossRef] [PubMed]
  13. Olech, M.; Rachid, A.; Croisé, B.; Kuźmak, J.; Valas, S. Genetic and antigenic characterization of small ruminant lentiviruses circulating in Poland. Virus Res. 2012, 163, 528–536. [Google Scholar] [CrossRef] [PubMed]
  14. Olech, M.; Valas, S.; Kuźmak, J. Epidemiological survey in single-species flocks from Poland reveals expanded genetic and antigenic diversity of small ruminant lentiviruses. PLoS ONE 2018, 13, e0193892. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Olech, M.; Murawski, M.; Kuźmak, J. Molecular analysis of small-ruminant lentiviruses in Polish flocks reveals the existence of a novel subtype in sheep. Arch. Virol. 2019, 164, 1193–1198. [Google Scholar] [CrossRef] [Green Version]
  16. Robinson, W.F. Chronic interstitial pneumonia in association with a granulomatous encephalitis in a goat. Aust. Vet. J. 1981, 57, 127–131. [Google Scholar] [CrossRef]
  17. Oliver, R.E.; Adams, D.S.; Gorham, J.R.; Julian, A.F.; McNiven, R.A.; Muir, J. Isolation of caprine arthritis-encephalitis virus from a goat. N. Z. Vet. J. 1982, 30, 147–149. [Google Scholar] [CrossRef]
  18. Sims, L.D.; Hale, C.J.; McCormick, B.M. Progressive interstitial pneumonia in goats. Aust. Vet. J. 1983, 60, 368–371. [Google Scholar] [CrossRef]
  19. Robinson, W.F.; Ellis, T.M. The pathological features of an interstitial pneumonia of goats. J. Comp. Pathol. 1984, 94, 55–64. [Google Scholar] [CrossRef]
  20. Hasegawa, M.Y.; Meira, E.B.S.; Lara, M.C.C.S.H.; Castro, R.S.; Rodrigues, J.N.M.; Araújo, J.; Keller, L.W.; Brandão, P.E.; Rizzo, H.; Barbosa, M.L.; et al. Small ruminant lentivirus variants and related clinical features in goats from southeastern Brazil. Small Rumin. Res. 2016, 140, 32–36. [Google Scholar] [CrossRef]
  21. Kaba, J.; Czopowicz, M.; Ganter, M.; Nowicki, M.; Witkowski, L.; Nowicka, D.; Szaluś-Jordanow, O. Risk factors associated with seropositivity to small ruminant lentiviruses in goat herds. Res. Vet. Sci. 2013, 94, 225–227. [Google Scholar] [CrossRef]
  22. Czopowicz, M.; Szaluś-Jordanow, O.; Mickiewicz, M.; Moroz, A.; Witkowski, L.; Bereznowski, A.; Markowska-Daniel, I.; Bagnicka, E.; Kaba, J. Relationship between the dissemination of small ruminant lentivirus infection in goat herds and opinion of farmers on the occurrence of arthritis. PLoS ONE 2018, 13, e0204134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Kaba, J.; Bagnicka, E.; Czopowicz, M.; Nowicki, M.; Witkowski, L.; Szaluś-Jordanow, O. Long-term study on the spread of caprine arthritis-encephalitis in a goat herd. Cent. Eur. J. Immunol. 2011, 36, 170–173. [Google Scholar]
  24. Kaba, J.; Czopowicz, M.; Nowicki, M.; Nowicka, D.; Witkowski, L.; Szaluś-Jordanow, O. Role Caprine Arthritis Encephalitis Virus (CAEV) Infection in The Occurrence of Particular Clinical Symptoms in Adult Goats. Bull. USAMV 2012, 69, 30–32. [Google Scholar]
  25. Anzuino, K.; Knowles, T.G.; Lee, M.R.F.; Grogono-Thomas, R. Survey of husbandry and health on UK commercial dairy goat farms. Vet. Rec. 2019, 185, 267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Mekibib, B.; Mikir, T.; Fekadu, A.; Abebe, R. Prevalence of Pneumonia in Sheep and Goats Slaughtered at Elfora Bishoftu Export Abattoir, Ethiopia: A Pathological Investigation. J. Vet. Med. 2019, 18, 5169040. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Ikheloa, J.O.; Ajuwape, A.T.P.; Adetosoye, A.I. Biochemical characterization and serological identification of mycoplasmas isolated from pneumonic lungs of goats slaughtered in abattoirs in Northern Nigeria. Small Rumin. Res. 2004, 52, 93–97. [Google Scholar] [CrossRef]
  28. Czopowicz, M.; Kaba, J.; Nowicki, M.; Nowicka, D.; Witkowski, L.; Szaluś-Jordanow, O. Long-Term Study on the Health Status of Polish Breeding Goat Population. Bull. USAMV 2012, 69, 329–334. [Google Scholar]
  29. Watt, N.J.; King, T.J.; Collie, D.; McIntyre, N.; Sargan, D.; McConnell, I. Clinicopathological investigation of primary, uncomplicated maedi-visna virus infection. Vet. Rec. 1992, 14, 455–461. [Google Scholar] [CrossRef]
  30. Herrmann-Hoesing, L.M.; Noh, S.M.; White, S.N.; Snekvik, K.R.; Truscott, T.; Knowles, D.P. Peripheral ovine progressive pneumonia provirus levels correlate with and predict histological tissue lesion severity in naturally infected sheep. Clin. Vaccine Immunol. 2009, 16, 551–557. [Google Scholar] [CrossRef] [Green Version]
  31. Dolka, I.; Tomaszewski, M.; Wola, D.; Czopowicz, M.; Kaba, J. Lymphoepithelial Cyst of the Salivary Gland in a Small Ruminant Lentivirus-Positive Goat. Animals 2020, 10, 1545. [Google Scholar] [CrossRef]
  32. Ellis, T.M.; Robinson, W.F.; Wilcox, G.E. The pathology and aetiology of lung lesions in goats infected with caprine arthritis-encephalitis virus. Aust. Vet. J. 1988, 65, 69–73. [Google Scholar] [CrossRef] [PubMed]
  33. Ayelet, G.; Roger, F.; Tibbo, M.; Tembely, S. Survey of maedi-visna (MV) in Ethiopian highland sheep. Vet. J. 2001, 161, 208–210. [Google Scholar] [CrossRef] [PubMed]
  34. Woldemeskel, M.; Tibbo, M.; Potgieter, L.N. Ovine progressive pneumonia (Maedi-Visna): An emerging respiratory disease of sheep in Ethiopia. Dtsch. Tierarztl. Wochenschr. 2002, 109, 486–488. [Google Scholar] [PubMed]
  35. Management Entity. Ethiopia’s Livestock Systems: Overview and Areas of Inquiry; Feed the Future Innovation Lab for Livestock Systems: Gainesville, FL, USA, 2021; Available online: https://livestocklab.ifas.ufl.edu/media/livestocklabifasufledu/pdf-/LSIL_Livestock_Systems_Overview_Ethiopia_2021_08.pdf (accessed on 11 March 2022).
  36. Dousti, M.; Sayyari, M.; Esmailnejad, A. Histopathological, serological, molecular and electron microscopy detection of Maedi-Visna infection in sheep population in the West of Iran. Iran J. Vet. Res. 2020, 21, 103–108. [Google Scholar] [PubMed]
  37. Mohan, K.; Obwolo, M.J.; Hill, F.W. Mycoplasma ovipneumoniae infection in Zimbabwean goats and sheep. J. Comp. Pathol. 1992, 107, 73–79. [Google Scholar] [CrossRef]
  38. Orós, J.; Fernández, A.; Rodríguez, J.L.; Rodríguez, F.; Poveda, J.B. Bacteria associated with enzootic pneumonia in goats. Zentralbl. Veterinarmed. B 1997, 44, 99–104. [Google Scholar] [CrossRef]
  39. Rodríguez, F.; Fernández, A.; Orós, J.; Ramírez, A.S.; Luque, R.; Ball, H.J.; Sarradell, J. Changes in lymphocyte subsets in the bronchus-associated lymphoid tissue of goats naturally infected with different Mycoplasma species. J. Vet. Med. B Infect. Dis. Vet. Public Health 2001, 48, 259–266. [Google Scholar] [CrossRef]
  40. Di Provvido, A.; Averaimo, D.; Zilli, K.; Marruchella, G.; Scacchia, M. Mycoplasma pneumonia in small ruminants: A ten-year long retrospective survey. Small Rumin. Res. 2017, 153, 103–106. [Google Scholar] [CrossRef]
  41. Donachie, W. Pasteurellosis. In Diseases of Sheep, 4th ed.; Aitken, I.D., Ed.; Blackwell Publishing: Oxford, UK, 2007; pp. 224–231. [Google Scholar]
  42. Jaÿ, M.; Ambroset, C.; Tricot, A.; Colin, A.; Tardy, F. Population structure and antimicrobial susceptibility of Mycoplasma ovipneumoniae isolates in France. Vet. Microbiol. 2020, 248, 108828. [Google Scholar] [CrossRef]
  43. Deeney, A.S.; Collins, R.; Ridley, A.M. Identification of Mycoplasma species and related organisms from ruminants in England and Wales during 2005–2019. BMC Vet. Res. 2021, 17, 325. [Google Scholar] [CrossRef]
  44. Chazel, M.; Tardy, F.; Le Grand, D.; Calavas, D.; Poumarat, F. Mycoplasmoses of ruminants in France: Recent data from the national surveillance network. BMC Vet. Res. 2010, 6, 32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Bölske, G.; Msami, H.; Humlesjö, N.E.; Ernø, H.; Jönsson, L. Mycoplasma capricolum in an outbreak of polyarthritis and pneumonia in goats. Acta Vet. Scand. 1988, 29, 331–338. [Google Scholar] [CrossRef] [PubMed]
  46. Nicholas, R.; Ayling, R.; McAuliffe, L. Mycoplasma Diseases of Ruminants. In Respiratory Diseases of Small Ruminants, 1st ed.; CABI International: Oxforshire, UK, 2008; pp. 169–198. [Google Scholar]
  47. Bednarek, D.; Ayling, R.D.; Nicholas, R.A.; Dudek, K.; Szymańska-Czerwinska, M. Serological survey to determine the occurrence of respiratory Mycoplasma infections in the Polish cattle population. Vet. Rec. 2012, 171, 45. [Google Scholar] [CrossRef]
  48. Murphy, B.G.; Castillo, D.; Mete, A.; Vogel, H.; Goldsmith, D.; Barro, M.; Gonzales-Viera, O. Caprine Arthritis Encephalitis Virus Is Associated with Renal Lesions. Viruses 2021, 13, 1051. [Google Scholar] [CrossRef] [PubMed]
  49. Storset, A.K.; Evensen, O.; Rimstad, E. Immunohistochemical identification of caprine arthritis-encephalitis virus in paraffin-embedded specimens from naturally infected goats. Vet. Pathol. 1997, 34, 180–188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. de la Concha-Bermejillo, A. Maedi-Visna and ovine progressive pneumonia. Vet. Clin. N. Am. Food Anim. Pract. 1997, 13, 13–33. [Google Scholar] [CrossRef]
  51. Pritchard, G.C.; McConnell, I. Maedi-visna. In Diseases of Sheep, 4th ed.; Aitken, I.D., Ed.; Blackwell Publishing: Oxford, UK, 2007; pp. 217–223. [Google Scholar]
  52. Narayan, O. Immunopathology of lentiviral infections in ungulate animals. Curr. Opin. Immunol. 1990, 2, 399–402. [Google Scholar] [CrossRef]
  53. Campbell, R.S.; Robinson, W.F. The comparative pathology of the lentiviruses. J. Comp. Pathol. 1998, 119, 333–395. [Google Scholar] [CrossRef]
  54. Blacklaws, B.A. Small ruminant lentiviruses: Immunopathogenesis of visna-maedi and caprine arthritis and encephalitis virus. Comp. Immunol. Microbiol. Infect. Dis. 2012, 35, 259–269. [Google Scholar] [CrossRef]
  55. Stonos, N.; Wootton, S.K.; Karrow, N. Immunogenetics of small ruminant lentiviral infections. Viruses 2014, 22, 3311–3333. [Google Scholar] [CrossRef]
  56. Urbańska, D.; Puchała, R.; Jarczak, J.; Czopowicz, M.; Kaba, J.; Horbańczuk, K.; Bagnicka, E. Does Small Ruminant Lentivirus Infection in Goats Predispose to Bacterial Infection of the Mammary Gland? A Preliminary Study. Animals 2021, 22, 1851. [Google Scholar] [CrossRef] [PubMed]
  57. Thrusfield, M. Veterinary Epidemiology, 4th ed.; John Wiley & Sons: Chichester, UK, 2018; pp. 324, 430–443. [Google Scholar]
  58. Rowe, J.D.; East, N.E.; Franti, C.E.; Thurmond, M.C.; Pedersen, N.C.; Theilen, G.H. Risk factors associated with the incidence of seroconversion to caprine arthritis-encephalitis virus in goats on California dairies. Am. J. Vet. Res. 1992, 53, 2396–2403. [Google Scholar] [PubMed]
  59. Blacklaws, B.A.; Berriatua, E.; Torsteinsdottir, S.; Watt, N.J.; de Andres, D.; Klein, D.; Harkiss, G.D. Transmission of small ruminant lentiviruses. Vet. Microbiol. 2004, 14, 199–208. [Google Scholar] [CrossRef]
  60. Moroz, A.; Biernacka, K.; Czopowicz, M.; Mickiewicz, M.; Abril, C.; Bertoni, G.; Ózsvári, L.; Petkevicius, S.; Stuen, S.; Samojlenko, M.; et al. CAE-RAPID—Genetic diversity of small ruminant lentivirus in Polish goat population. In Proceedings of the XXI Middle European Buiatrics Congress, Stare Jabłonki, Poland, 19–22 May 2022; p. 184. [Google Scholar]
  61. Clavijo, A.; Thorsen, J. Serologic diagnosis of caprine arthritis-encephalitis by ELISA with two recombinant proteins in a parallel testing format. J. Immunoass. 1995, 16, 419–436. [Google Scholar] [CrossRef] [PubMed]
  62. Nowicka, D.; Czopowicz, M.; Mickiewicz, M.; Szaluś-Jordanow, O.; Witkowski, L.; Bagnicka, E.; Kaba, J. Diagnostic performance of ID screen MVV-CAEV Indirect Screening ELISA in identifying small ruminant lentiviruses-infected goats. Pol. J. Vet. Sci. 2014, 17, 501–506. [Google Scholar] [CrossRef] [PubMed]
  63. Moroz, A.; Czopowicz, M.; Mickiewicz, M.; Witkowski, L.; Szaluś-Jordanow, O.; Nalbert, T.; Klimowicz-Bodys, M.D.; Markowska-Daniel, I.; Bagnicka, E.; Kaba, J. Antibodies to parainfluenza virus type 3 in goat population in Poland. Pol. J. Vet. Sci. 2021, 24, 235–241. [Google Scholar] [PubMed]
  64. Martin, W.B. Respiratory infections of sheep. Comp. Immunol. Microbiol. Infect. Dis. 1996, 19, 171–179. [Google Scholar] [CrossRef]
  65. Georgsson, G.; Pálsson, P.A. The histopathology of maedi a slow, viral pneumonia of sheep. Vet. Pathol. 1971, 8, 63–80. [Google Scholar] [CrossRef] [Green Version]
  66. Luján, L.; Begara, I.; Collie, D.; Watt, N.J. Ovine lentivirus (maedi-visna virus) protein expression in sheep alveolar macrophages. Vet. Pathol. 1994, 31, 695–703. [Google Scholar] [CrossRef]
  67. Feldman, D.B.; Gupta, B.N. Histopathologic changes in laboratory animals resulting from various methods of euthanasia. Lab. Anim. Sci. 1976, 26, 218–221. [Google Scholar]
  68. Brogden, K.A.; Lehmkuhl, H.D.; Cutlip, R.C. Pasteurella haemolytica complicated respiratory infections in sheep and goats. Vet. Res. 1998, 29, 233–254. [Google Scholar] [PubMed]
  69. Ribeiro, M.G.; Risseti, R.M.; Bolaños, C.A.; Caffaro, K.A.; de Morais, A.C.; Lara, G.H.; Zamprogna, T.O.; Paes, A.C.; Listoni, F.J.; Franco, M.M. Trueperella pyogenes multispecies infections in domestic animals: A retrospective study of 144 cases (2002 to 2012). Vet. Q. 2015, 35, 82–87. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Altman, D.; Machin, D.; Bryant, T.; Gardner, M. Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed.; BMJ Books: Bristol, UK, 2000; pp. 46–47. [Google Scholar]
Pathogens 11 00629 g001 550
Figure 1. The severity of three pneumonia types in a study goat population: chronic interstitial pneumonia (CIP), purulent bronchopneumonia (PBP), and fibrinous pleuropneumonia (FPP).
Figure 1. The severity of three pneumonia types in a study goat population: chronic interstitial pneumonia (CIP), purulent bronchopneumonia (PBP), and fibrinous pleuropneumonia (FPP).
Pathogens 11 00629 g001
Pathogens 11 00629 g002 550
Figure 2. The prevalence of three pneumonia types in a study goat population: chronic interstitial pneumonia (CIP), purulent bronchopneumonia (PBP), and fibrinous pleuropneumonia (FPP).
Figure 2. The prevalence of three pneumonia types in a study goat population: chronic interstitial pneumonia (CIP), purulent bronchopneumonia (PBP), and fibrinous pleuropneumonia (FPP).
Pathogens 11 00629 g002
Pathogens 11 00629 g003 550
Figure 3. Histopathological lesions observed in the chronic interstitial pneumonia (CIP): (A) lymphatic nodules hyperplasia (peribronchial and perivascular), interstitial (i.e., peribronchiolar and perialveolar) inflammatory infiltrates composed of macrophages and lymphocytes, interalveolar septum thickening, 100×, H-E; (B) interstitial (i.e., peribronchiolar and perialveolar) inflammatory infiltrates composed of macrophages and lymphocytes, interalveolar septum thickening, 200×, H-E; (C) smooth muscle hyperplasia in the walls of the bronchioles, 400×, H-E; and (D) interstitial connective tissue hyperplasia, 200×, Masson.
Figure 3. Histopathological lesions observed in the chronic interstitial pneumonia (CIP): (A) lymphatic nodules hyperplasia (peribronchial and perivascular), interstitial (i.e., peribronchiolar and perialveolar) inflammatory infiltrates composed of macrophages and lymphocytes, interalveolar septum thickening, 100×, H-E; (B) interstitial (i.e., peribronchiolar and perialveolar) inflammatory infiltrates composed of macrophages and lymphocytes, interalveolar septum thickening, 200×, H-E; (C) smooth muscle hyperplasia in the walls of the bronchioles, 400×, H-E; and (D) interstitial connective tissue hyperplasia, 200×, Masson.
Pathogens 11 00629 g003
Pathogens 11 00629 g004 550
Figure 4. Histopathological lesions observed in the purulent bronchopneumonia (PBP), 400×, H-E: (A) peribronchial inflammatory infiltrates composed of neutrophils and lymphocytes, purulent exudate in the lumen of bronchus; (B) focal necrosis of lung parenchyma; and (C) focal atelectasis.
Figure 4. Histopathological lesions observed in the purulent bronchopneumonia (PBP), 400×, H-E: (A) peribronchial inflammatory infiltrates composed of neutrophils and lymphocytes, purulent exudate in the lumen of bronchus; (B) focal necrosis of lung parenchyma; and (C) focal atelectasis.
Pathogens 11 00629 g004
Pathogens 11 00629 g005 550
Figure 5. Histopathological lesions observed in the fibrinous pleuropneumonia pattern (FPP): (A) subpleural accumulation of fibrin, 200×, H-E; (B) subpleural accumulation of fibrin, 400×, Weigert; and (C) subpleural connective tissue hyperplasia, 400×, Masson.
Figure 5. Histopathological lesions observed in the fibrinous pleuropneumonia pattern (FPP): (A) subpleural accumulation of fibrin, 200×, H-E; (B) subpleural accumulation of fibrin, 400×, Weigert; and (C) subpleural connective tissue hyperplasia, 400×, Masson.
Pathogens 11 00629 g005
Pathogens 11 00629 g006 550
Figure 6. Representative images of immunohistochemistry (IHC) examination of caprine lung samples. The immunoreactivity for small ruminant lentivirus (SRLV) was developed with DAB chromogen (brown precipitate in the cell’s cytoplasm) and counterstained with Mayer’s hematoxylin (A–D) positive immunostaining and (E,F) negative controls: (A) the bronchiole lined by SRLV-positive epithelial cells (black arrowheads), 200×; (B) the SRLV-positive bronchial epithelial cells (black arrowhead) and a macrophage (white arrowhead) in the peribronchial inflammatory cells, 400×; (C) the SRLV-positive macrophages scattered in the thickened alveolar septa (white arrowheads), 200×; (D) the positive immunostaining of SRLV in the cytoplasm of the bronchial epithelial cells (black arrowhead) and macrophages (white arrowhead), 400×; (E) a negative tissue control, 200×; and (F) an isotype control, 200×.
Figure 6. Representative images of immunohistochemistry (IHC) examination of caprine lung samples. The immunoreactivity for small ruminant lentivirus (SRLV) was developed with DAB chromogen (brown precipitate in the cell’s cytoplasm) and counterstained with Mayer’s hematoxylin (A–D) positive immunostaining and (E,F) negative controls: (A) the bronchiole lined by SRLV-positive epithelial cells (black arrowheads), 200×; (B) the SRLV-positive bronchial epithelial cells (black arrowhead) and a macrophage (white arrowhead) in the peribronchial inflammatory cells, 400×; (C) the SRLV-positive macrophages scattered in the thickened alveolar septa (white arrowheads), 200×; (D) the positive immunostaining of SRLV in the cytoplasm of the bronchial epithelial cells (black arrowhead) and macrophages (white arrowhead), 400×; (E) a negative tissue control, 200×; and (F) an isotype control, 200×.
Pathogens 11 00629 g006
Table
Table 1. The occurrence of histopathological lesions in the lungs of goats with symptomatic caprine arthritis-encephalitis (CAE).
Table 1. The occurrence of histopathological lesions in the lungs of goats with symptomatic caprine arthritis-encephalitis (CAE).
Histopathological LesionN (%) of Goats with a Lesionn (% of N)
of Goats with a Lesion of
Particular Severity
MildModerateSevere
Chronic Interstitial Pneumonia (CIP)
1Interstitial inflammatory infiltrate composed of macrophages and lymphocytes101 (87.1)72 (71.3)17 (16.8)12 (11.9)
2Interstitial connective tissue hyperplasia72 (62.1)48 (66.7)14 (19.4)10 (13.9)
3Lymphoid follicles formation69 (59.5)51 (73.9)14 (20.3)4 (5.8)
4Smooth muscle hyperplasia34 (29.3)32 (94.2)1 (2.9)1 (2.9)
5Interstitial septum thickening 16 (13.8)14 (87.5)0 (0)2 (12.5)
6Pneumocyte hyperplasia6 (5.2)3 (50.0)2 (33.3)1 (16.7)
Purulent Bronchopneumonia (PBP)
1Peribronchial inflammatory infiltrate composed of neutrophils and lymphocytes114 (98.3)85 (74.6)16 (14.0)13 (11.4)
2Perivascular inflammatory infiltrate composed of neutrophils and lymphocytes95 (81.9)77 (81.1)6 (6.3)12 (12.6)
3Emphysema26 (22.4)26 (100)0 (0)0 (0)
4Bronchial exudate17 (14.7)9 (52.9)1 (5.9)7 (41.2)
5Atelectasis13 (11.2)12 (92.3)1 (7.7)0 (0)
6Necrosis of lung parenchyma10 (8.6)9 (90.0)1 (10.0)0 (0)
Fibrinous Pleuropneumonia (FPP)
1Subpleural connective tissue hyperplasia68 (58.6)53 (77.9)8 (11.8)7 (10.3)
2Subpleural fibrin accumulation27 (23.3)27 (100)0 (0)0 (0)
3Interstitial fibrin accumulation15 (12.9)14 (93.3)0 (0)1 (6.7)
Table
Table 2. The occurrence of bacteria in the lungs of symptomatic small ruminant lentivirus (SRLV)-seropositive goats.
Table 2. The occurrence of bacteria in the lungs of symptomatic small ruminant lentivirus (SRLV)-seropositive goats.
Bacterial SpeciesNo. of Goats InfectedPrevalence (CI 95%)
Gram-Positive
Trueperella pyogenes1613.8 (8.7–21.2)
Staphylococcus spp.97.8 (4.1–14.1)
Staphylococcus aureus86.9 (3.5–13.0)
Coagulase-negative staphylococci10.9 (0.2–4.7)
Others
Enterococcus sp.97.8 (4.1–14.1)
α-hemolytic Streptococcus sp.65.2 (2.4–10.8)
Corynebacterium pseudotuberculosis65.2 (2.4–10.8)
Gram-Negative
Enterobacterales2420.7 (14.3–28.9)
Escherichia coli2016.8 (11.2–24.5)
Proteus sp.32.6 (0.9–7.3)
Enterobacter sp.10.9 (0.2–4.7)
Pasteurellaceae1411.8 (7.1–18.8)
Mannheimia hemolytica86.7 (3.4–12.7)
Pasteurella multocida65.2 (2.4–10.8)
Others
Pseudomonas aeruginosa32.6 (0.9–7.3)
Alcaligenes sp.10.9 (0.2–4.7)
Acinetobacter sp.10.9 (0.2–4.7)
Table
Table 3. Chronic interstitial pneumonia (CIP) as a risk factor for other respiratory system-associated conditions.
Table 3. Chronic interstitial pneumonia (CIP) as a risk factor for other respiratory system-associated conditions.
Respiratory System-Associated ConditionsCIP (n (% of N))Prevalence Ratio (CI 95%)p-Value
Present (N = 67)Absent (N = 49)
Purulent bronchopneumonia (PBP) 39 (58.2)9 (18.4)3.17 (1.70–5.92)<0.001
Fibrinous pleuropneumonia (FPP) 30 (44.8)8 (16.3)4.16 (1.69–10.2)0.001
Infection with potential etiological agents of bacterial pneumonia28 (41.8)12 (24.5)1.71 (0.97–3.01)0.050
Corynebacterium pseudotuberculosis infection3 (4.5)3 (6.1)0.73 (0.15–3.47)0.696
Presence of accidental/commensal microorganisms18 (26.9)15 (30.6)0.88 (0.49–1.56)0.659
Antibodies to Corynebacterium pseudotuberculosis phospholipase D antigen38 (56.7)32 (65.3)0.87 (0.65–1.16)0.349
Concentration of antibodies to parainfluenza virus type 3 (PIV-3) (ng/mL)257, 173–540
(75–1494)		296, 146–53
(39–1454)		–0.898
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Moroz, A.; Czopowicz, M.; Sobczak-Filipiak, M.; Dolka, I.; Rzewuska, M.; Kizerwetter-Świda, M.; Chrobak-Chmiel, D.; Mickiewicz, M.; Witkowski, L.; Szaluś-Jordanow, O.; et al. The Prevalence of Histopathological Features of Pneumonia in Goats with Symptomatic Caprine Arthritis-Encephalitis. Pathogens 2022, 11, 629. https://doi.org/10.3390/pathogens11060629

AMA Style

Moroz A, Czopowicz M, Sobczak-Filipiak M, Dolka I, Rzewuska M, Kizerwetter-Świda M, Chrobak-Chmiel D, Mickiewicz M, Witkowski L, Szaluś-Jordanow O, et al. The Prevalence of Histopathological Features of Pneumonia in Goats with Symptomatic Caprine Arthritis-Encephalitis. Pathogens. 2022; 11(6):629. https://doi.org/10.3390/pathogens11060629

Chicago/Turabian Style

Moroz, Agata, Michał Czopowicz, Małgorzata Sobczak-Filipiak, Izabella Dolka, Magdalena Rzewuska, Magdalena Kizerwetter-Świda, Dorota Chrobak-Chmiel, Marcin Mickiewicz, Lucjan Witkowski, Olga Szaluś-Jordanow, and et al. 2022. "The Prevalence of Histopathological Features of Pneumonia in Goats with Symptomatic Caprine Arthritis-Encephalitis" Pathogens 11, no. 6: 629. https://doi.org/10.3390/pathogens11060629

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop